In the double blind placebo controlled studies 529 patients were treated with rasagiline 1 mg/ day for 212 patient years and 539 patients received placebo for 213 patient years.
Topeltpimedates platseebokontrollitud uuringutes raviti 529 patsienti rasagiliiniga annuses 1 mg/ päevas 212 patsiendiaasta jooksul ja 539 patsienti said platseebot 213 patsiendiaasta jooksul.